Notice: AIChE Customer Service telephone lines have been temporarily impacted by Tropical Storm Isaias. Most calls will reach a representative, however, if you have an issue please email email@example.com and we will respond as soon as possible. We apologize for any inconvenience.
Massimo Morbidelli, former Professor at the Universita' degli Studi di Cagliari, is currently Professor and Decano at the Dipartimento di Chimica, Materiali e Ingegneria Chimica del Politecnico di Milano and Emeritus Professor at the Department of Chemistry and Applied Biosciences at the ETH Zurich, where he served as Department chairman in the period 2012 – 2014. He received his Laurea in Chemical Engineering from the Politecnico di Milano and his Ph.D. in Chemical Engineering from the University of Notre Dame (USA). His research interests include reaction, polymer and colloidal engineering, and more recently the continuous manufacturing of therapeutic proteins. In this area he cofounded ChromaCon AG (Continuous Chromatography Technologies for Protein Purification, currently part of the Japanese YMC group), and DataHow AG (Big Data in Bioprocessing) of which he is currently President. He is the first chemical engineer to become member of the Italian Academy of Sciences (Accademia dei Lincei) and is the recipient of several awards including the R.H. Wilhelm and the Excellence in Process Development Research Award of the American Institute of Chemical Engineers, the Separation Science and Technology Award of the American Chemical Society, the Integrated Continuous Biomanufacturing Award, the Gerhard Damköhler-Medaille from DECHEMA and VDI-GVC, the Laurea Honoris Causa from the Technical University of Bratislava, the Seminario Gianni Astarita from the Università Federico II, Napoli as well as the Golden Awl Award, Best Teacher of the Year, Department of Chemistry and Applied Biosciences, ETH Zurich. He serves as Executive Editor for the Industrial & Engineering Chemistry Research Journal of the American Chemical Society. He is the co-author of more than 700 refereed journal publications as well as 23 patents and 6 books, including the very recent ones on Continuous Biopharmaceutical Processes (2018) coauthored with D. Pfister and L. Nicoud, and Perfusion Cell Culture Processes for Biopharmaceuticals (2020) coauthored with M. Wolf and J.-M. Bielser, both from Cambridge University Press. He completed more than 100 PhD students at the Universita' degli Studi di Cagliari, Politecnico di Milano and ETH Zurich.